Kharasch E D
Division of Clinical and Translational Research, Department of Anesthesiology, Washington University, St. Louis, Missouri, USA.
Clin Pharmacol Ther. 2008 Jul;84(1):158-62. doi: 10.1038/clpt.2008.97. Epub 2008 May 28.
Problems with organ toxicity from the halogenated volatile anesthetics have influenced clinical practice, anesthetic selection, and drug development for half a century.(1,2) In turn, investigations that elucidated the mechanisms of volatile anesthetics adverse effects identified new mechanisms, provided remarkable insights into human toxicology, and represented seminal contributions to clinical pharmacology. This review focuses on adverse organ effects (hepatic, renal, and others) that are attributable to anesthetic metabolism and/or degradation. Routine reversible effects on pulmonary, cardiac, and other organ functions are not addressed.
半个世纪以来,卤代挥发性麻醉药的器官毒性问题一直影响着临床实践、麻醉剂选择和药物研发。(1,2)反过来,阐明挥发性麻醉药不良反应机制的研究发现了新机制,为人类毒理学提供了卓越见解,并对临床药理学做出了开创性贡献。本综述重点关注归因于麻醉药代谢和/或降解的器官不良反应(肝脏、肾脏及其他)。对肺、心脏和其他器官功能的常规可逆性影响不在讨论范围内。